← All MEPs

Daniel Caspary

European Parliament · 🇩🇪 Germany · former MEP

Term: from 18 July 2019 to 24 February 2026

Participation in roll-call votes

91 % of the 2,244 roll-call votes held during their term: took part in the vote (for, against or abstention)

Participation month by month

0 % 50 % 100 % July 2019 : participation 100 % (1 / 1), presence 100 % (1 / 1) 2019 September 2019 : participation 100 % (5 / 5), presence 100 % (5 / 5) October 2019 : participation 21 % (4 / 19), presence 21 % (4 / 19) November 2019 : participation 94 % (17 / 18), presence 94 % (17 / 18) December 2019 : participation 100 % (6 / 6), presence 100 % (6 / 6) January 2020 : participation 100 % (12 / 12), presence 100 % (12 / 12) 2020 February 2020 : participation 100 % (8 / 8), presence 100 % (8 / 8) May 2020 : participation 100 % (54 / 54), presence 100 % (54 / 54) June 2020 : participation 100 % (12 / 12), presence 100 % (12 / 12) July 2020 : participation 100 % (19 / 19), presence 100 % (19 / 19) September 2020 : participation 100 % (24 / 24), presence 100 % (24 / 24) October 2020 : participation 100 % (37 / 37), presence 100 % (37 / 37) November 2020 : participation 100 % (32 / 32), presence 100 % (32 / 32) December 2020 : participation 100 % (30 / 30), presence 100 % (30 / 30) January 2021 : participation 100 % (23 / 23), presence 100 % (23 / 23) 2021 February 2021 : participation 100 % (21 / 21), presence 100 % (21 / 21) March 2021 : participation 100 % (31 / 31), presence 100 % (31 / 31) April 2021 : participation 100 % (81 / 81), presence 100 % (81 / 81) May 2021 : participation 100 % (26 / 26), presence 100 % (26 / 26) June 2021 : participation 100 % (29 / 29), presence 100 % (29 / 29) July 2021 : participation 100 % (27 / 27), presence 100 % (27 / 27) September 2021 : participation 100 % (19 / 19), presence 100 % (19 / 19) October 2021 : participation 100 % (42 / 42), presence 100 % (42 / 42) November 2021 : participation 96 % (26 / 27), presence 96 % (26 / 27) December 2021 : participation 100 % (29 / 29), presence 100 % (29 / 29) January 2022 : participation 100 % (7 / 7), presence 100 % (7 / 7) 2022 February 2022 : participation 100 % (29 / 29), presence 100 % (29 / 29) March 2022 : participation 97 % (36 / 37), presence 97 % (36 / 37) April 2022 : participation 91 % (20 / 22), presence 91 % (20 / 22) May 2022 : participation 85 % (75 / 88), presence 85 % (75 / 88) June 2022 : participation 91 % (42 / 46), presence 91 % (42 / 46) July 2022 : participation 68 % (21 / 31), presence 68 % (21 / 31) September 2022 : participation 96 % (24 / 25), presence 96 % (24 / 25) October 2022 : participation 91 % (29 / 32), presence 91 % (29 / 32) November 2022 : participation 24 % (9 / 38), presence 24 % (9 / 38) December 2022 : participation 89 % (16 / 18), presence 89 % (16 / 18) January 2023 : participation 81 % (13 / 16), presence 81 % (13 / 16) 2023 February 2023 : participation 97 % (28 / 29), presence 97 % (28 / 29) March 2023 : participation 55 % (16 / 29), presence 55 % (16 / 29) April 2023 : participation 100 % (24 / 24), presence 100 % (24 / 24) May 2023 : participation 97 % (90 / 93), presence 97 % (90 / 93) June 2023 : participation 90 % (36 / 40), presence 90 % (36 / 40) July 2023 : participation 98 % (39 / 40), presence 98 % (39 / 40) September 2023 : participation 96 % (26 / 27), presence 96 % (26 / 27) October 2023 : participation 95 % (38 / 40), presence 95 % (38 / 40) November 2023 : participation 100 % (53 / 53), presence 100 % (53 / 53) December 2023 : participation 95 % (38 / 40), presence 95 % (38 / 40) January 2024 : participation 96 % (47 / 49), presence 96 % (47 / 49) 2024 February 2024 : participation 75 % (47 / 63), presence 75 % (47 / 63) March 2024 : participation 84 % (42 / 50), presence 84 % (42 / 50) April 2024 : participation 89 % (190 / 213), presence 89 % (190 / 213) July 2024 : participation 100 % (1 / 1), presence 100 % (1 / 1) September 2024 : participation 100 % (8 / 8), presence 100 % (8 / 8) October 2024 : participation 92 % (12 / 13), presence 92 % (12 / 13) November 2024 : participation 100 % (27 / 27), presence 100 % (27 / 27) December 2024 : participation 61 % (11 / 18), presence 61 % (11 / 18) January 2025 : participation 100 % (6 / 6), presence 100 % (6 / 6) 2025 February 2025 : participation 100 % (10 / 10), presence 100 % (10 / 10) March 2025 : participation 79 % (11 / 14), presence 79 % (11 / 14) April 2025 : participation 100 % (22 / 22), presence 100 % (22 / 22) May 2025 : participation 100 % (54 / 54), presence 100 % (54 / 54) June 2025 : participation 91 % (20 / 22), presence 91 % (20 / 22) July 2025 : participation 81 % (26 / 32), presence 81 % (26 / 32) September 2025 : participation 100 % (29 / 29), presence 100 % (29 / 29) October 2025 : participation 98 % (44 / 45), presence 98 % (44 / 45) November 2025 : participation 71 % (36 / 51), presence 71 % (36 / 51) December 2025 : participation 97 % (30 / 31), presence 97 % (30 / 31) January 2026 : participation 91 % (20 / 22), presence 91 % (20 / 22) 2026 February 2026 : participation 68 % (19 / 28), presence 68 % (19 / 28)

Their votes

2,244 votes

DateTextResultTheir vote
The draft Commission implementing regulation amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances benfluralin, dimoxystrobin, fluazinam, flutolanil, mancozeb, mecoprop-P, mepiquat, metiram, oxamyl and pyraclostrobin Against
Cuba, the case of Jose Daniel Ferrer Absent
The climate and environment emergency Against
The EU's accession to the Istanbul Convention and other measures to combat gender-based violence For
The EU's accession to the Istanbul Convention and other measures to combat gender-based violence Against
The crisis of the WTO Appellate Body For
Recent actions by the Russian Federation against Lithuanian judges, prosecutors and investigators involved in investigating the tragic events of 13 January 1991 in Vilnius For
The situation in Bolivia For
The 2019 UN Climate Change Conference in Madrid, Spain (COP 25) For
EU/USA Agreement on the Allocation of a Share in the Tariff Rate Quota for imports of high-quality beef For
Children’s rights on the occasion of the 30th anniversary of the UN Convention on the Rights of the Child For
Children’s rights on the occasion of the 30th anniversary of the UN Convention on the Rights of the Child Against
Children’s rights on the occasion of the 30th anniversary of the UN Convention on the Rights of the Child Against
The criminalisation of sexual education in Poland For
The draft Commission implementing decision renewing the authorisation for the placing on the market of products containing, consisting of or produced from genetically modified soybean MON 89788 (MON-89788-1) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council Against
The draft Commission implementing decision authorising the placing on the market of products containing, consisting of or produced from genetically modified maize MON 89034 × 1507 × NK603 × DAS-40278-9 and sub-combinations MON 89034 × NK603 × DAS-40278-9, 1507 × NK603 × DAS-40278-9 and NK603 × DAS-40278-9, pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council Against
The draft Commission implementing decision authorising the placing on the market of products containing, consisting of or produced from genetically modified maize Bt11 × MIR162 × MIR604 × 1507 × 5307 × GA21 and genetically modified maize combining two, three, four or five of the single events Bt11, MIR162, MIR604, 1507, 5307 and GA21 pursuant to Regulation (EC) No 1829/2003 of the European… Against
The draft Commission implementing decision renewing the authorisation for the placing on the market of products containing, consisting of or produced from genetically modified cotton LLCotton25 (ACS-GHØØ1-3) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council Against
Mobilisation of the European Globalisation Adjustment Fund: redundancies in the retail trade sector in Belgium For
Opening accession negotiations with North Macedonia and Albania Absent
The situation of LGBTI people in Uganda Absent
Search and rescue in the Mediterranean (SAR) Absent
The draft Commission implementing decision partially granting an authorisation for a use of chromium trioxide under Regulation (EC) No 1907/2006 of the European Parliament and of the Council (Cromomed S.A. and others) Absent
The state of play on the proposal for a directive of the European Parliament and of the Council amending Directive 2013/34/EU as regards disclosure of income tax information by certain undertakings and branches (2016/0107(COD)), known as public country-by-country reporting Absent
The draft Commission regulation amending Regulation (EU) No 546/2011 as regards the assessment of the impact of plant protection products on honeybees Against
2020 general budget: all sections For
2017 discharge: European Asylum Support Office (EASO) For
2017 discharge: EU general budget, European Council and Council For
The 2021-2027 multiannual financial framework and own resources: time to meet citizens' expectations Absent
The draft Commission implementing decision authorising the placing on the market of products containing, consisting of or produced from genetically modified maize MZHG0JG (SYN-ØØØJG-2), pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council Absent
The draft Commission implementing decision authorising the placing on the market of products containing, consisting of or produced from genetically modified maize MON 89034 × 1507 × MON 88017 × 59122 × DAS-40278-9 and genetically modified maize combining two, three or four of the single events MON 89034, 1507, MON 88017, 59122 and DAS-40278-9 pursuant to Regulation (EC) No 1829/2003 of the… Absent
The draft Commission implementing decision renewing the authorisation for the placing on the market of products containing, consisting of or produced from genetically modified soybean A2704-12 (ACS-GMØØ5-3) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council Absent
The draft Commission implementing regulation amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances amidosulfuron, beta-cyfluthrin, bifenox, chlorotoluron, clofentezine, clomazone, cypermethrin, daminozide, deltamethrin, dicamba, difenoconazole, diflubenzuron, diflufenican, fenoxaprop-P, fenpropidin, fludioxonil, flufenacet… Absent
Commission Implementing Regulation (EU) 2019/707 of 7 May 2019 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances alpha-cypermethrin, beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, cyazofamid, desmedipham, dimethoate, dimethomorph, diuron, ethephon, etoxazole, famoxadone, fenamiphos… Absent
Employment and social policies of the euro area Absent
Foreign electoral interference and disinformation in national and European democratic processes Absent
Flexibility Instrument: adjustments to the amounts mobilised for 2019 to be used for migration, refugee inflows and security threats Absent
Amending budget 4/2019: reduction of commitment and payment appropriations in line with updated needs of expenditure and update of revenue (own resources) Absent
The importance of European remembrance for the future of Europe For
Iran, notably the situation of women’s rights defenders and imprisoned EU dual nationals For

Rows per page: 20 40 100 200 All